Skeletal Muscle Aging and Responsiveness in Aged People With MS
Recruiting now · Not applicable
Conditions studied: Multiple Sclerosis, Aging
In brief
The purposes of this study are to: 1) compare baseline muscle and cardiovascular health in older individuals (\>60 years old) diagnosed with MS to age-matched people without MS, 2) determine muscle and whole body changes to an exercise training program, 3) determine if the muscle in a more affected leg in individuals diagnosed with MS is different from the muscle of a less affected leg, and 4) if or how individuals diagnosed with MS adapt differently than age-matched people without MS to exercise training. Participation in this study will average 1.5 hours per visit, 3 visits per week, for approximately 4 months.
Key facts
- Study ID
- NCT07500727
- Run by
- Oklahoma Medical Research Foundation
- People needed
- 10
- Starts
- 2026-03-06
- Expected to finish
- 2026-12-31
- Last updated by the study team
- 2026-03-30
Who can join
Age: 60 and older. Sex: any. Healthy volunteers: not accepted.
You may qualify if…
- 1. Male or female aged 60 or above 2. Free of unmanaged chronic diseases other than multiple sclerosis 3. No structured exercise program (2 or more bouts/wk) within previous 6 months 4. Cognitively capable of providing informed consent 5. Must meet EDSS score between 2 to 5.5 during screening
You may not qualify if…
- 1. Neuromuscular or musculoskeletal disorder, other than multiple sclerosis, that would limit the ability to perform the exercise and/or testing bouts.
- Cardiopulmonary disorders or reduced breathing capacity
- Metabolic diseases including markers of liver disease (ALT > 52 U/dl) and type 2 diabetes (HbA1C ≥ 6.5, fasting blood glucose ≥ 126 mg/dl)
- Taking any dose of metformin
- Any other disease or disorder that would influence exercise response (e.g., chronic kidney disease, Alzheimer's, current cancer diagnosis or within 2 yr remission, cerebrovascular)
- History of Chemotherapy within 5 years
- Unchangeable anticoagulant (Coumadin, Pradaxa, etc.) use. To be determined by clinical staff.
- Insulin sensitizing/blood glucose lowering (e.g., metformin) or metabolic (GLP1 agonists) drugs.
- High dose statin (40 mg and above)
- Have a non-correctable visual impairment
- Score less than 29 on the Symbol Digit Test
- Received Botox for spasticity within the prior 3 months of study participation.
- Cannot have any adjustments to Baclofen during study participation.
- Unable to commit to \~4 months required to complete the study.
- Lidocaine allergy
- Tobacco use
- Excessive alcohol consumption (3 drinks/d or 7 drinks/wk for females; 4 drinks/day or drinks/wk for males)
- BMI greater than 35.0 kg/m2
Where it is running
- Oklahoma Medical Research Foundation — Oklahoma City, Oklahoma, United States (enrolling)
Full record on ClinicalTrials.gov
Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.